Efficacy of Memantine ER on Activities of Daily Living: A Post Hoc Responder Analysis From a Randomized Trial in Patients With Moderate-to-severe Alzheimer's Disease

被引：0
|
作者：
Alva, Gustavo [1 ]
Grossberg, George [2 ]
Hendrix, Suzanne [3 ]
Ellison, Noel [3 ]
Andersen, Kristen A. [4 ]
Edwards, John [5 ]
机构：
[1] ATP Clin Res, Costa Mesa, CA USA
[2] St Louis Univ, St Louis, MO 63103 USA
[3] Pentara Corp, Salt Lake City, UT USA
[4] Prescott Med Commun Grp, Chicago, IL USA
[5] Allergan Plc, Jersey City, NJ USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P3.087
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Combined application of tenuigenin and β-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer's disease
    Chang, Wenguang
    Teng, Junfang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 455 - 462
  • [32] Efficacy of Memantine by Baseline Disease Severity: A Pooled Post-Hoc Analysis of Trials in Mild to Moderate Alzheimer's Disease
    Tocco, Michael
    Hendrix, Suzanne
    Miller, Michael L.
    Pejovic, Vojislav
    Graham, Stephen M.
    ANNALS OF NEUROLOGY, 2011, 70 : S55 - S55
  • [33] Memantine in Japanese patients with moderate to severe Alzheimer's disease: meta-analysis of multiple-index responder analyses
    Okuizumi, Kaoru
    Kamata, Teruyoshi
    Matsui, Daiju
    Saito, Kengo
    Matsumoto, Takuyuki
    Fukuchi, Yoshikazu
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (05) : 425 - 430
  • [34] Memantine prevents worsening of communication abilities in patients with moderate to severe Alzheimer's disease: Mean change- and responder analysis
    Tariot, P. N.
    Saxton, J.
    Tocco, M.
    Hofbauer, R. K.
    Resnick, M.
    Graham, S. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S104 - S104
  • [35] The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer's Disease Taking Cholinesterase Inhibitors
    Grossberg, George T.
    Manes, Facundo
    Allegri, Ricardo F.
    Miguel Gutierrez-Robledo, Luis
    Gloger, Sergio
    Xie, Lei
    Jia, X. Daniel
    Pejovic, Vojislav
    Miller, Michael L.
    Perhach, James L.
    Graham, Stephen M.
    CNS DRUGS, 2013, 27 (06) : 469 - 478
  • [36] The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors
    George T. Grossberg
    Facundo Manes
    Ricardo F. Allegri
    Luis Miguel Gutiérrez-Robledo
    Sergio Gloger
    Lei Xie
    X. Daniel Jia
    Vojislav Pejović
    Michael L. Miller
    James L. Perhach
    Stephen M. Graham
    CNS Drugs, 2013, 27 : 469 - 478
  • [37] Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
    Tariot, PN
    Farlow, MR
    Grossberg, GT
    Graham, SM
    McDonald, S
    Gergel, I
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (03): : 317 - 324
  • [38] Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan
    Nakamura, Yu
    Kitamura, Shin
    Homma, Akira
    Shiosakai, Kazuhito
    Matsui, Daiju
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 913 - 925
  • [39] Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer’s Disease
    Anders Wimo
    Bengt Winblad
    Albrecht Stöffler
    Yvonne Wirth
    Hans-Jörg Möbius
    PharmacoEconomics, 2003, 21 : 327 - 340
  • [40] Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD
    Hellweg, Rainer
    Wirth, Yvonne
    Janetzky, Wolfgang
    Hartmann, Susanne
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 27 (06) : 651 - 656
12345